NYSE:CVSHealthcare
Can CVS Health (CVS) Trade At A Premium After FTC Settlement?
CVS Health stock has delivered a strong 83.1% return over the past year, yet the broader valuation checks and current market multiples suggest the shares are not an obvious bargain at today’s level.
The 83.1% one year gain signals a powerful rerating that raises the bar for what future cash flows and earnings need to justify.
Recent legal and regulatory developments around drug pricing and pharmacy practices can support investor confidence if they reduce uncertainty over time, but they also...